We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+11.35%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81.6B
AUM Growth
+$7.7B
(+10%)
Cap. Flow
+$798M
Cap. Flow
% of AUM
0.98%
Top 10 Holdings %
Top 10 Hldgs %
23.85%
Holding
3,095
New
53
Increased
1,513
Reduced
1,408
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$65.3M |
| 2 |
Amazon
AMZN
|
+$50M |
| 3 |
Tesla
TSLA
|
+$30.5M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$26.6M |
| 5 |
EPAM Systems
EPAM
|
+$26.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KSU
Kansas City Southern
KSU
|
+$39.1M |
| 2 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$31.2M |
| 3 |
XEC
CIMAREX ENERGY CO
XEC
|
+$23.4M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$21.9M |
| 5 |
SBNY
Signature Bank
SBNY
|
+$17.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.54% |
| 2 | Financials | 13.15% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PAE
2376
DELISTED
PAE Incorporated Class A Common Stock
PAE
| $684K | ﹤0.01% |
68,914
-1,082
| -2% | -$9.66K |
|
2377
Scholar Rock
SRRK
$6.44B
| $683K | ﹤0.01% |
27,487
-864
| -3% | -$23.8K |
|
|
RAPT
2378
DELISTED
RAPT Therapeutics
RAPT
| $682K | ﹤0.01% |
2,320
+208
| +10% | +$55.6K |
|
2379
Business First Bancshares
BFST
$1.03B
| $681K | ﹤0.01% |
24,063
+383
| +2% | +$10.4K |
|
2380
Aclaris Therapeutics
ACRS
$869M
| $679K | ﹤0.01% |
46,725
+1,424
| +3% | +$21.6K |
|
|
GHL
2381
DELISTED
Greenhill & Co., Inc.
GHL
| $679K | ﹤0.01% |
37,889
-2,272
| -6% | -$39.1K |
|
2382
Boston Omaha
BOC
$436M
| $678K | ﹤0.01% |
23,582
+2,894
| +14% | +$94.5K |
|
|
KZR
2383
DELISTED
Kezar Life Sciences
KZR
| $677K | ﹤0.01% |
4,047
+54
| +1% | +$6.1K |
|
2384
4D Molecular Therapeutics
FDMT
$562M
| $674K | ﹤0.01% |
30,715
+6,177
| +25% | +$151K |
|
|
ATRS
2385
DELISTED
Antares Pharma, Inc.
ATRS
| $673K | ﹤0.01% |
188,613
-71,322
| -27% | -$249K |
|
2386
Ouster
OUST
$2.92B
| $672K | ﹤0.01% |
12,918
+10,617
| +461% | +$689K |
|
|
IDEX
2387
DELISTED
Ideanomics, Inc. Common Stock
IDEX
| $670K | ﹤0.01% |
4,465
+28
| +0.6% | +$5.97K |
|
2388
Personalis
PSNL
$1.51B
| $669K | ﹤0.01% |
46,861
-1,488
| -3% | -$24.8K |
|
2389
UFP Technologies
UFPT
$2.43B
| $669K | ﹤0.01% |
9,518
-115
| -1% | -$7.62K |
|
|
AGEN
2390
Agenus
AGEN
$290M
| $668K | ﹤0.01% |
10,565
-39
| -0.4% | -$3.08K |
|
2391
SI-BONE Inc
SIBN
$834M
| $661K | ﹤0.01% |
29,757
-459
| -2% | -$9.88K |
|
2392
Life Time Group Holdings
LTH
$9.79B
| $659K | ﹤0.01% |
+38,286
| New | +$715K |
|
2393
Tidewater
TDW
$4.12B
| $659K | ﹤0.01% |
61,513
-715
| -1% | -$8.4K |
|
2394
Veritone
VERI
$122M
| $659K | ﹤0.01% |
29,333
+484
| +2% | +$12.4K |
|
|
VERV
2395
DELISTED
Verve Therapeutics
VERV
| $657K | ﹤0.01% |
17,824
+184
| +1% | +$7.73K |
|
|
RIDE
2396
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
| $657K | ﹤0.01% |
12,696
+3,393
| +36% | +$246K |
|
2397
First Internet Bancorp
INBK
$255M
| $655K | ﹤0.01% |
13,919
-7
| -0.1% | -$283 |
|
2398
Regional Management Corp
RM
$303M
| $652K | ﹤0.01% |
11,347
-172
| -1% | -$9.82K |
|
2399
Oppenheimer Holdings
OPY
$1.2B
| $650K | ﹤0.01% |
14,023
-168
| -1% | -$8.28K |
|
|
EGIO
2400
DELISTED
Edgio, Inc. Common Stock
EGIO
| $650K | ﹤0.01% |
4,741
+24
| +0.5% | +$2.85K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2021 Portfolio in Review
As of Q4 2021, RhumbLine Advisers held 3,095 positions worth $81.6B, up 10% from $73.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Trading was light in Q4 2021: portfolio turnover was 4.4%. RhumbLine Advisers opened 53 new positions and exited 84, leaving the 3,095-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2021 buy was Rivian: 125,331 shares worth $13M.
- RhumbLine Advisers added most to Microsoft in Q4 2021, an estimated $65.3M increase.
- RhumbLine Advisers's biggest Q4 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $21.9M.
- RhumbLine Advisers fully exited Kansas City Southern in Q4 2021, selling an estimated $39.1M.
- RhumbLine Advisers's ten largest holdings make up 24% of its $81.6B portfolio in Q4 2021.
- RhumbLine Advisers opened 53 new positions and closed 84 in Q4 2021.
- RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $81.6B.
Based on RhumbLine Advisers's 13F filing for Q4 2021, filed 10 Feb 2022.